{"title":"接受双膦酸盐治疗的乳腺癌患者的牙科植入物","authors":"Mai Ashraf Talaat","doi":"10.18231/j.jooo.2023.041","DOIUrl":null,"url":null,"abstract":"This review article aims to assess the success of dental implants in breast cancer patients receiving bisphosphonate therapy, and to evaluate the risk of developing bisphosphonate related osteonecrosis of the jaw following dental implant surgery.Breast cancer patients undergoing bisphosphonate therapy may receive dental implants. However, the risk of developing BRONJ and implant failure is quite high. Risk factors such as the type of BP received, the route of administration, and the length of treatment prior to surgery should be considered.","PeriodicalId":509247,"journal":{"name":"Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology","volume":"182 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dental implants in breast cancer patients receiving bisphosphonate therapy\",\"authors\":\"Mai Ashraf Talaat\",\"doi\":\"10.18231/j.jooo.2023.041\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This review article aims to assess the success of dental implants in breast cancer patients receiving bisphosphonate therapy, and to evaluate the risk of developing bisphosphonate related osteonecrosis of the jaw following dental implant surgery.Breast cancer patients undergoing bisphosphonate therapy may receive dental implants. However, the risk of developing BRONJ and implant failure is quite high. Risk factors such as the type of BP received, the route of administration, and the length of treatment prior to surgery should be considered.\",\"PeriodicalId\":509247,\"journal\":{\"name\":\"Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology\",\"volume\":\"182 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18231/j.jooo.2023.041\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.jooo.2023.041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
这篇综述文章旨在评估接受双膦酸盐治疗的乳腺癌患者种植牙的成功率，并评估种植牙手术后发生与双膦酸盐相关的颌骨坏死的风险。接受双膦酸盐治疗的乳腺癌患者可能会接受牙科植入物治疗，但罹患 BRONJ 和植入物失败的风险相当高。应考虑风险因素，如接受的 BP 类型、给药途径和手术前的治疗时间。
Dental implants in breast cancer patients receiving bisphosphonate therapy
This review article aims to assess the success of dental implants in breast cancer patients receiving bisphosphonate therapy, and to evaluate the risk of developing bisphosphonate related osteonecrosis of the jaw following dental implant surgery.Breast cancer patients undergoing bisphosphonate therapy may receive dental implants. However, the risk of developing BRONJ and implant failure is quite high. Risk factors such as the type of BP received, the route of administration, and the length of treatment prior to surgery should be considered.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
